Regeneron Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 21,632 | 0.1% | 28,026 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 15,217 | 0.1% | 27,063 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 14,152 | 0.1% | 26,956 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 16,754 | 0.1% | 26,417 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 17,187 | 0.1% | 24,125 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 24,471 | 0.2% | 23,278 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 22,447 | 0.1% | 21,357 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 18,249 | 0.1% | 18,960 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 12,880 | 0.1% | 14,665 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 11,453 | 0.1% | 13,917 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 9,366 | 0.1% | 13,035 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 10,720 | 0.1% | 13,047 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 9,713 | 0.1% | 13,463 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 9,827 | 0.1% | 14,266 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 8,102 | 0.1% | 13,706 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 9,181 | 0.1% | 13,146 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 8,129 | 0.1% | 12,872 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 7,529 | 0.1% | 12,441 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 7,153 | 0.1% | 12,807 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 6,258 | 0.1% | 13,227 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 6,543 | 0.1% | 13,544 | 12/31/2020 |
| 2020 Q3 | 10/20/2020 | 7,240 | 0.1% | 12,934 | 9/30/2020 |
| 2020 Q2 | 7/27/2020 | 8,369 | 0.2% | 13,420 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 11,618 | 0.3% | 23,793 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 14,533 | 0.3% | 38,706 | 12/31/2019 |